FIELD: medicine.
SUBSTANCE: invention relates to medicine. Therapeutic or prophylactic drug used for prophylactic and/or treatment constipation, in which inhibiting compound SGLT1 4-isopropylphenylglucitol represented by formula (I) or pharmaceutically acceptable salts thereof are contained as an active ingredient.
(I).
EFFECT: drug is chemically stable and unaffected by metabolism in the digestive tract environment comprising the stomach through the small intestine, rapidly exhibits its efficacy in small enough amounts; exhibited its efficacy while undergoing little absorption in vivo from the small intestine, it exerts less side effects even when used in more-than-effective amounts.
1 cl, 4 dwg, 1 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| C-PHENYL-1-THIOGLUCITOLS | 2007 |
|
RU2434862C2 |
| 4-ISOPROPYLPHENYLGLUCITE DERIVATIVES AS SGLT1 INHIBITORS | 2010 |
|
RU2518896C2 |
| NEW GLUCITOL DERIVATIVE, PRODRUG AND SALT AND THERAPEUTIC AGENT CONTAINING THEM FOR DIABETES TREATMENT | 2005 |
|
RU2386631C2 |
| PHENYLTETRAHYDROISOQUINOLINE COMPOUND, SUBSTITUTED WITH HETEROARYL | 2015 |
|
RU2703456C2 |
| CONDENSED HETEROCYCLIC DERIVATIVES MEDICAL COMPOSITIONS CONTAINING THEM AND THEIR MEDICAL APPLICATION | 2005 |
|
RU2387663C2 |
| NEW PIPERIDINE COMPOUND OR SALT THEREOF | 2013 |
|
RU2581834C1 |
| PYRAZOLE COMPOUNDS SUBSTITUTED BY HETEROARYL AND THEIR APPLICATION IN PHARMACEUTICS | 2019 |
|
RU2805312C2 |
| C-PHENYL GLYCITOL COMPOUND FOR TREATING DIABETES | 2007 |
|
RU2437876C2 |
| TRICYCLIC COMPOUND AND JAK INHIBITOR | 2015 |
|
RU2674262C2 |
| ANTICANCER PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2419430C2 |
